Detalhe da pesquisa
1.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561027
2.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036397
3.
Assessing the Dissemination of COVID-19 Articles Across Social Media With Altmetric and PlumX Metrics: Correlational Study.
J Med Internet Res
; 23(1): e21408, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406049
4.
Retraction: "Assessing the Dissemination of COVID-19 Articles Across Social Media With Altmetric and PlumX Metrics: Correlational Study".
J Med Internet Res
; 24(8): e41544, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947853
5.
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
Lancet Infect Dis
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513684
6.
Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven by Schistosoma mansoni infection in humans.
Trop Med Int Health
; 18(6): 750-60, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23496801
7.
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
J Allergy Clin Immunol
; 130(1): 169-76.e6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22633322
8.
Assessment of the Dissemination of COVID-19-Related Articles Across Social Media: Altmetrics Study.
JMIR Form Res
; 7: e41388, 2023 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343075
9.
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
PLoS Negl Trop Dis
; 17(3): e0011236, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996185
10.
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Nat Med
; 29(9): 2334-2346, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640860
11.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
medRxiv
; 2023 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333252
12.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
medRxiv
; 2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034641
13.
Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults.
Vaccine
; 40(42): 6084-6092, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114129
14.
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
medRxiv
; 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898343
15.
A history of hookworm vaccine development.
Hum Vaccin
; 7(11): 1234-44, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22064562
16.
Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
Lancet Infect Dis
; 21(2): 275-285, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926834
17.
Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon.
PLoS Negl Trop Dis
; 15(10): e0009732, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597297
18.
Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
PLoS Negl Trop Dis
; 14(8): e0008670, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804987
19.
Hookworm vaccines.
Clin Infect Dis
; 46(2): 282-8, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18171264
20.
Lessons along the Critical Path: Developing Vaccines against Human Helminths.
Trends Parasitol
; 34(9): 747-758, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064902